NEW YORK, NY--(Marketwired - May 29, 2014) - Kadmon Corporation, LLC, today announced that Samuel D. Waksal, Ph.D., Chairman and Chief Executive Officer, will present at the Jefferies 2014 Global Healthcare Conference on Wednesday, June 4th at 11:00 a.m. EDT in New York City. Dr. Waksal will provide an overview of Kadmon and its commercial and clinical programs.
A live audio webcast of the presentation will be accessible through Kadmon’s website at www.kadmon.com. The webcast will be archived for 90 days.
About Kadmon Corporation
Kadmon Corporation, LLC, is a global company built on a 21st-century paradigm for the translation of innovative science into treatment. The company currently offers products and services for the treatment and management of liver diseases, and is pioneering novel medicines in areas of serious disease, including oncology, immunology and infectious, neurodegenerative and ophthalmic diseases. Emphasizing emerging concepts in molecular biology and genomics, Kadmon is developing treatments and treatment combinations that target the metabolomics and signaling pathways associated with disease, with the goal of addressing some of today’s most pressing areas of unmet medical need. For more information, visit www.kadmon.com.
Contact Information
David Pitts
Argot Partners
212.600.1902
Email Contact
Help employers find you! Check out all the jobs and post your resume.
